LRRK2 and Parkinson disease: In addition, LRRK2 is induced in both human monocytes and T cells following an inflammatory stimulus; and in PD patients there is a positive correlation between LRRK2 levels, MHC-II induction, cytokine expression and secretion levels, and dampened expression of the T-cell inhibitory factor CTLA-4.